Browsing Norwegian Institute of Public Health Open Repository by Author "Kjerpeseth, Lars Jøran"
Now showing items 1-5 of 5
-
Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in nonvalvular atrial fibrillation: A nationwide pharmacoepidemiological study
Kjerpeseth, Lars Jøran; Selmer, Randi Marie; Ariansen, Inger; Karlstad, Øystein; Ellekjær, Hanne; Skovlund, Eva (Peer reviewed; Journal article, 2019)Objective: To compare effectiveness and safety of warfarin and the direct oral anticoagulants (DOAC) dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation in routine care. Methods: From nationwide ... -
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries
Komen, Joris J.; Pottegård, Anton; Mantel-Teeuwisse, Aukje K.; Forslund, Tomas; Hjemdahl, Paul; Wettermark, Björn; Hellfritzsch, Maja; Hallas, Jesper; Olesen, Morten; Bennie, Marion; Mueller, Tanja; Voss, Annemarie; Schink, Tania; Haug, Ulrike; Kollhorst, Bianca; Karlstad, Øystein; Kjerpeseth, Lars Jøran; Klungel, Olaf H. (Peer reviewed; Journal article, 2021) -
Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation
Kjerpeseth, Lars Jøran; Ellekjær, Hanne; Selmer, Randi; Ariansen, Inger Kristine Holtermann; Furu, Kari; Skovlund, Eva (Peer reviewed; Journal article, 2018) -
Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015
Kjerpeseth, Lars Jøran; Ellekjær, Hanne; Selmer, Randi; Ariansen, Inger Kristine; Furu, Kari; Skovlund, Eva (Peer reviewed; Journal article, 2017) -
Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015
Kjerpeseth, Lars Jøran; Ellekjær, Hanne; Selmer, Randi; Ariansen, Inger Kristine; Furu, Kari; Skovlund, Eva (Peer reviewed; Journal article, 2017)